Early Discharge from the Emergency Department Based on Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels: A TRIAGE III Substudy
Table 2
30-day mortality of patients discharged within 24 hours. Groups were created based on the presence (suPAR group) or absence (control group) of suPAR at the index admission.
Mortality, no. patients (%)
suPAR group
52 (1.3)
Control group
77 (1.8)
suPAR level at index admission (ng/mL)
Alive, median (IQR)
3.5 (2.6–4.7)
Dead, median (IQR)
8.5 (6.7–11.8)
Logistic regression models, OR (95% CI)
Unadjusted
0.73 (0.51–1.04)
Adjusted for age, sex, hospital, haemoglobin, and albumin level
0.80 (0.54–1.19)
Fully adjusted, all baseline variables
0.74 (0.49–1.12)
Area under the curve (95% CI)
Age
0.87 (0.83–0.91)
Albumin
0.86 (0.81–0.91)
Creatinine
0.73 (0.65–0.82)
CRP
0.81 (0.75–0.80)
Haemoglobin
0.76 (0.70–0.84)
suPAR
0.92 (0.90–0.95)
CI: confidence interval; CRP: C-reactive protein; IQR: interquartile range; OR: odds ratio for the suPAR group compared to the control group; suPAR: soluble urokinase plasminogen activator receptor. .
